OMEGA HEALTHCARE INVESTORS INC (OHI)
As-reported financials and recent SEC filings for OMEGA HEALTHCARE INVESTORS INC, latest fiscal period FY2025. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.
About OMEGA HEALTHCARE INVESTORS INC
Omega Healthcare Investors Inc is a real estate investment trust that owns and invests in healthcare-related properties in the United States, United Kingdom, and Canada. Its portfolio includes skilled nursing facilities, assisted living facilities, independent living facilities, specialty hospitals, and continuing care retirement communities. The company leases these properties primarily under triple-net leases to third-party healthcare operators and also operates some facilities through management agreements under RIDEA structures.
Snapshot
Fundamentals are from SEC filings. P/E and market cap are derived from recent market prices, refreshed on a rolling basis (typically within the past week).
What changed at Omega Healthcare Investors
- Revenue grew 13.2% to $1.2B in FY2025, faster than the 10.7% the year before.
- Most recent quarter Q1 FY2026: revenue $323M, up 16.7% from Q1 FY2025.
- Net income rose 45.2% to $590M in FY2025.
Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.
Peer comparison
Where Omega Healthcare Investors’s fundamentals sit among the 165 REITs. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).
Omega Healthcare Investors’s net margin of 49.6% ranks in the 93rd percentile of the 156 REITs reporting it. Omega Healthcare Investors’s revenue growth of +13.2% ranks in the 86th percentile of the 161 REITs reporting it. Omega Healthcare Investors’s return on equity of 10.8% ranks in the 85th percentile of the 141 REITs reporting it.
No open-market insider transactions recorded in the last 90 days. For context, about 16% of companies in the universe saw any open-market insider buying in the same window. Browse insider activity →
Percentiles describe where a figure sits among industry peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.
Institutional ownership
Held by 1 of the superinvestors we track (plus 6 quant / multi-strat books), based on each investor’s most recent 13F (latest Q1 2026).
| Investor | As of | Position value | Shares | Change |
|---|---|---|---|---|
| AQR Capital Managementquant | Q1 2026 | $103.3M | 2.4M | Reduced |
| Two Sigma Investmentsquant | Q1 2026 | $95.9M | 2.2M | Added |
| D. E. Shawquant | Q1 2026 | $70.5M | 1.6M | Added |
| Gotham Asset Management | Q1 2026 | $36.5M | 833.1K | Added |
| Renaissance Technologiesquant | Q1 2026 | $27.4M | 625.4K | Added |
| Millennium Managementquant | Q1 2026 | $13.0M | 296.1K | Reduced |
| Point72 Asset Managementquant | Q1 2026 | $2.4M | 54.2K | Reduced |
No longer held by: Citadel Advisors (as of Q1 2026)
From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.
Short interest
Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 2026-07-15 | 13.3M | -6.0% | 8.55 |
| 2026-06-30 | 14.1M | +1.9% | 5.82 |
| 2026-06-15 | 13.8M | +1.8% | 4.90 |
| 2026-05-29 | 13.6M | +6.3% | 6.37 |
| 2026-05-15 | 12.8M | +6.4% | 5.60 |
| 2026-04-30 | 12.0M | +7.2% | 4.83 |
| 2026-04-15 | 11.2M | -3.2% | 5.87 |
| 2026-03-31 | 11.6M | -13.2% | 6.06 |
Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.
Income statement (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | $1.19B | $1.05B | $949.7M | $878.2M | $1.06B |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $590.2M | $406.3M | $242.2M | $438.8M | $428.3M |
| Diluted EPS | $1.94 | $1.55 | $1.00 | $1.80 | $1.75 |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full methodology.
Balance sheet (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Cash and equivalents | $27.0M | $518.3M | $442.8M | $297.1M | $20.5M |
| Current assets | — | — | — | — | — |
| Total assets | $10.05B | $9.90B | $9.12B | $9.41B | $9.64B |
| Current liabilities | — | — | — | — | — |
| Long-term debt | $4.26B | $4.84B | $5.07B | $5.29B | $5.25B |
| Total liabilities | $4.61B | $5.17B | $5.36B | $5.60B | $5.53B |
| Total equity | $5.44B | $4.73B | $3.76B | $3.80B | $4.11B |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full methodology.
Cash flow (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Operating cash flow | $878.6M | $749.4M | $617.7M | $625.7M | $722.1M |
| Capital expenditure | — | — | — | — | — |
| Free cash flow | — | — | — | — | — |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full methodology.
Quarterly trend (as reported)
| Quarter | Revenue | Revenue YoY | Net income | Diluted EPS |
|---|---|---|---|---|
| Q1 FY2026 | $323.0M | 16.7% | $151.0M | $0.47 |
| Q4 FY2025 | $319.2M | 14.3% | $164.8M | $0.53 |
| Q3 FY2025 | $311.6M | 12.9% | $179.7M | $0.59 |
| Q2 FY2025 | $282.5M | 11.8% | $136.6M | $0.46 |
| Q1 FY2025 | $276.8M | 13.8% | $109.0M | $0.33 |
| Q4 FY2024 | $279.3M | 16.7% | $113.3M | $0.39 |
| Q3 FY2024 | $276.0M | 14.0% | $111.8M | $0.42 |
| Q2 FY2024 | $252.7M | 1.0% | $113.9M | $0.45 |
Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.
Company facts
Recent SEC filings
Largest reit peers
Monitor OHI
Get an alert when Omega Healthcare Investors files something material, see which superinvestors own it, and ask its filings a question with cited answers.
Monitor OHI freeIncludes one free filing-grounded research answer. Or check your whole portfolio, no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.